Delivery Notice! Your parcel will be delivered within 2 business days after placing your order. Dismiss
Sale!

Emoclot 500iu/10ml Human Plasma Coagulation Factor VIII Infusion In Pakistan

Original price was: ₨34,500.00.Current price is: ₨32,500.00.

🛡️ Buyer Protection
Full Refund for Damages
🔐 Privacy Assured
We Never Share Your Details
📦 Cash on Delivery
Pay When Your Order Arrives
🎁 Exclusive Deals
Special Offers Available
🚀 Fast Delivery
Quick Dispatch Across Pakistan
🕐 Same Day Dispatch
For Orders Placed Before 2 PM
WhatsApp us

Emoclot 500iu/10ml Human Plasma Coagulation Factor VIII Infusion In Pakistan

Emoclot 500 IU/10 mL is a human plasma-derived coagulation Factor VIII medicine manufactured by Kedrion. It is supplied as lyophilized powder with a 10 mL solvent and is reconstituted before intravenous infusion. It is used as Factor VIII replacement therapy for the treatment and prevention of bleeding associated with Hemophilia A and Factor VIII deficiency.

Benefits

  • Replaces deficient human coagulation Factor VIII.
  • Helps control bleeding episodes associated with Hemophilia A.
  • Can be used for prevention of bleeding when prescribed as prophylactic therapy.
  • May be used in certain cases of acquired Factor VIII deficiency.
  • Provides plasma-derived Factor VIII for intravenous replacement therapy.

Specifications

Specification Details
Brand Emoclot
Active Ingredient Human Plasma Coagulation Factor VIII
Strength 500 IU
Reconstituted Strength 50 IU/mL
Total Volume 10 mL
Form Lyophilized Powder + Solvent
Route Intravenous infusion
Manufacturer Kedrion S.p.A., Italy
Source Human donor plasma
Prescription Prescription medicine
Storage Generally 2–8°C; do not freeze

The product information identifies one vial as containing 500 IU Factor VIII, reconstituted with 10 mL water for injection to give approximately 50 IU/mL. It also contains human von Willebrand factor.

How To Use

  • Emoclot should be administered intravenously by a healthcare professional experienced in hemophilia treatment.
  • The required dose and frequency depend on the severity and location of bleeding, the patient’s Factor VIII level, body weight, and clinical response.
  • The powder must be reconstituted with the supplied solvent according to the official instructions before administration.
  • Factor VIII levels may be monitored during treatment to determine the appropriate dose and frequency of subsequent infusions.
  • Do not self-administer or determine the dose yourself. Follow the hematologist’s prescription and the product leaflet.

Why Choose Emoclot?

Emoclot offers human plasma-derived Factor VIII replacement therapy in a 500 IU/10 mL presentation. Its established use in Factor VIII deficiency makes it a prescription treatment option for patients requiring Factor VIII replacement under specialist supervision.

Reviews

There are no reviews yet.

Be the first to review “Emoclot 500iu/10ml Human Plasma Coagulation Factor VIII Infusion In Pakistan”

Your email address will not be published. Required fields are marked *

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total ₨0.00